PeptidesRx review

What it is

PeptidesRx (PeptidesRx LLC, 1650 W Rosedale St, Suite 302, Fort Worth, Texas) is a telehealth platform selling prescription compounded peptides and GLP-1 medications from a single catalog. Its range spans GH secretagogues (sermorelin in injection, nasal spray and troche forms, sermorelin/ipamorelin, CJC-1295/ipamorelin, tesamorelin, GHRP-2, ibutamoren), recovery peptides (BPC-157, TB-500, KPV and their blends), longevity compounds (GHK-Cu, epitalon, MOTS-C, thymosin alpha-1, ARA-290, methylene blue, sirolimus), neuro items (NAD⁺, semax and selank), sexual health (PT-141, oxytocin), testosterone cypionate and gonadorelin, brand growth hormone, and compounded semaglutide, tirzepatide and retatrutide. It positions itself explicitly as a compliance-first alternative to gray-market research-chemical sellers.

How it works

Video-gated and subscription-shaped. You enrol, meet a licensed provider by video for a good-faith exam, and a prescription — if issued — goes to a compounding pharmacy for shipping, with one good-faith exam stated to cover every item in your protocol cart. Two structural claims stand out and are worth crediting. It states its providers are board-certified nurse practitioners and physicians who are W-2 employees of its medical group rather than independent contractors, which is a real accountability argument almost nobody in this category makes. And it advertises PCAB-accredited compounding pharmacies; PCAB accreditation is a genuine third-party standard beyond state licensure. Two claims cut the other way. The site advertises meeting a provider "in as little as 30 seconds", which is difficult to reconcile with a meaningful good-faith exam for injectable prescriptions and deserves a hard look. And while its catalog data carries a pharmacy name against most items, that field is not rendered on the product cards, so a shopper never sees which facility is making their vial. No individual clinician, medical director or state list is published either.

Pricing transparency

The best-specified pricing on this board, and the easiest to misread. Every item is priced "per supply" with the supply defined: sermorelin from $55 for 3 mg in a 3 mL vial at 1 mg/mL described as roughly fifteen days, $80 for 15 mg in a 5 mL vial at 3 mg/mL described as roughly fifty days, $77 for a 30 mL nasal spray described as roughly a hundred days, $75 for thirty 600 mcg troches. CJC-1295/ipamorelin is $100 for a 5 mL vial at 2 mg/2 mg per mL. BPC-157 with TB-500 is $100 for a five-week supply. NAD⁺ runs $80 for 1,000 mg in a 10 mL vial at 100 mg/mL, up to $160 for 2,000 mg at 200 mg/mL. Testosterone cypionate is $59 for a 10 mL vial at 200 mg/mL described as a monthly supply. Now the trap: the cart states a monthly total that renews automatically, so a vial the catalog calls a fifty-day supply is charged every thirty days. That is not a per-month price and we publish no floor for it. Ask precisely what cadence you will be billed on and whether the shipment interval matches the supply length.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The site states that all prescriptions come from licensed US providers, that medication is compounded by licensed US pharmacies pursuant to a valid prescription, and — in its own footer — that compounded medications are not FDA-approved drug products, which is the correct disclosure. Compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, this catalog is a masterclass in why a price list is not a recommendation. Sermorelin, CJC-1295/ipamorelin and tesamorelin act on the growth-hormone axis; tesamorelin is an approved drug for HIV-associated lipodystrophy specifically, and the others have real mechanisms with thin long-term outcome data. BPC-157, TB-500, GHK-Cu, epitalon, MOTS-C and thymosin alpha-1 have essentially no controlled human outcome trials. Injected NAD⁺ has none; oral NR and NMN raise a biomarker. PT-141 is approved for one narrow indication in premenopausal women, so prescribing it to anyone else is off-label use. Testosterone cypionate is an approved molecule requiring ongoing haematocrit, PSA and testosterone monitoring. A catalog this wide will always be wider than the evidence. Individual results vary.

Pros and watch-outs

The evidence behind what PeptidesRx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides

  They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.

• BPC 157: what the evidence actually shows (and what it doesn't)

  The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

• TB-500 and thymosin beta-4: separating the trials from the hype

  Real Phase 2 dry-eye data, deep preclinical neuro/cardiac work, and a recovery-market use that was never actually tested.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

• PT-141 (bremelanotide): the evidence on a research-popular peptide that is actually FDA-approved

  Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How PeptidesRx compares

A few alternatives worth a look, depending on what you’re optimizing for.

• OHOurView Health

  Shoppers who will get the membership terms in writing before comparing the NAD⁺ price

  See OurView Health →
• PAPauseRX

  NAD⁺ buyers who want a named 503A pharmacy and a named prescribing network

  See PauseRX →
• PLPlexusDx

  NAD⁺ at a published all-in monthly price with check-ins and no membership on top

  See PlexusDx →